These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 214326)

  • 1. Studies on the hydrolysis of bradykinin by angiotensin-converting enzyme (kininase II).
    Dorer FE; Stewart JM; Ryan JW
    Experientia; 1978 Nov; 34(11):1436. PubMed ID: 214326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of digestion of bradykinin and lysylbradykinin (kallidin) in human serum. Role of carboxypeptidase, angiotensin-converting enzyme and determination of final degradation products.
    Sheikh IA; Kaplan AP
    Biochem Pharmacol; 1989 Mar; 38(6):993-1000. PubMed ID: 2539165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tripeptidyl carboxypeptidase activity of kininase II (angiotensin-converting enzyme).
    Inokuchi J; Nagamatsu A
    Biochim Biophys Acta; 1981 Dec; 662(2):300-7. PubMed ID: 6274413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selectivity of converting-enzyme inhibitors for angiotensin I versus bradykinin hydrolysis reactions.
    Brooks RR; Miller KE; Jones SM; Burns RH; Huang CT
    J Pharm Sci; 1990 May; 79(5):384-8. PubMed ID: 2161922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of specific inhibitors of angiotensin I converting enzyme (kininase II).
    Cushman DW; Cheung HS; Sabo EF; Rubin B; Ondetti MA
    Fed Proc; 1979 Dec; 38(13):2778-82. PubMed ID: 228989
    [No Abstract]   [Full Text] [Related]  

  • 6. Angiotensin-converting enzyme: I. New strategies for assay.
    Ryan JW; Chung A; Ryan US
    Environ Health Perspect; 1980 Apr; 35():165-70. PubMed ID: 6250809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of vasoactive peptides by human endothelial cells in culture. Angiotensin I converting enzyme (kininase II) and angiotensinase.
    Johnson AR; Erdös EG
    J Clin Invest; 1977 Apr; 59(4):684-95. PubMed ID: 191471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cleavage of des-Arg9-bradykinin by angiotensin I-converting enzyme from pig kidney cortex.
    Oshima G; Hiraga Y; Shirono K; Oh-ishi S; Sakakibara S; Kinoshita T
    Experientia; 1985 Mar; 41(3):325-8. PubMed ID: 2982643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The angiotensin I converting enzyme.
    Erdös EG
    Fed Proc; 1977 Apr; 36(5):1760-5. PubMed ID: 191298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for rabbit brain neuropeptide-metabolizing peptidases. Inhibition of endopeptidase B by bradykinin potentiating peptide 9a (SQ 20881).
    Martins AR; Caldo H; Coelho HL; Moreira AC; Antunes-Rodrigues J; Greene LJ; Martins de Camargo AC
    J Neurochem; 1980 Jan; 34(1):100-7. PubMed ID: 6161209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of the digestion of bradykinin, Lys-bradykinin, and des-Arg9-bradykinin by angiotensin converting enzyme.
    Sheikh IA; Kaplan AP
    Biochem Pharmacol; 1986 Jun; 35(12):1951-6. PubMed ID: 3013204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent inhibition of angiotensin-converting enzyme by [des-Pro3]-bradykinin or "converstatin" in comparison with Captopril.
    Okuda M; Arakawa K
    J Biochem; 1985 Sep; 98(3):621-8. PubMed ID: 3003038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of new peptide inhibitors on the ratio of angiotensin I-converting and kinin-degrading activities of dipeptidyl carboxypeptidase (angiotensin-converting enzyme).
    Kalinina EV; Posdnev VF; Komissarova NV; Gomazkov OA
    Biochemistry (Mosc); 1997 Mar; 62(3):247-50. PubMed ID: 9275297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme substrates hydrolyzed by fibroblasts and vascular endothelial cells.
    Rubin DB; Mason RJ; Dobbs LJ
    Exp Lung Res; 1982 May; 3(2):137-45. PubMed ID: 6179773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of brain endopeptidases: influence of size and sequence of substrates structurally related to bradykinin.
    Oliveira EB; Martins AR; Camargo AC
    Biochemistry; 1976 May; 15(9):1967-74. PubMed ID: 5120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-domain angiotensin I converting enzyme (kininase II): characterization and properties.
    Deddish PA; Wang LX; Jackman HL; Michel B; Wang J; Skidgel RA; Erdös EG
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1582-9. PubMed ID: 8968386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a new bradykinin-potentiating peptide (TmF) from Trimeresurus mucrosquamatus.
    Jia YH; Li DS; Zhu SW; Zhang LY; Ding LS; Wang WY; Xiong YL
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Jul; 35(7):619-23. PubMed ID: 12883631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective inhibition of the C-domain of angiotensin I converting enzyme by bradykinin potentiating peptides.
    Cotton J; Hayashi MA; Cuniasse P; Vazeux G; Ianzer D; De Camargo AC; Dive V
    Biochemistry; 2002 May; 41(19):6065-71. PubMed ID: 11994001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin converting enzyme (ACE) and neprilysin hydrolyze neuropeptides: a brief history, the beginning and follow-ups to early studies.
    Skidgel RA; Erdös EG
    Peptides; 2004 Mar; 25(3):521-5. PubMed ID: 15134871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the inhibition of angiotensin converting enzyme on renin release mediated by exercise in man [proceedings].
    Khokhar AM; Havard CW; Slater JD
    J Endocrinol; 1979 Oct; 83(1):37P-38P. PubMed ID: 230274
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.